Research Article
Association Analysis of LEP Signaling Pathway with Type 2 Diabetes Mellitus in Chinese Han Population from South China
Table 4
Results of association analysis between LEP signaling pathway allele and type2 diabetes.
| Gene | SNP | Allele | Nondiabetic controls | T2DM patients | value | OR (95% CI) | A | a | MAF | A | a | MAF | Observed | Adjusted | Observed | Adjusted |
| LEP | rs4731426 | C/G | 1488 | 620 | 0.294 | 1460 | 674 | 0.316 | 0.132 | 0.141 | 1.11 (0.97-1.26) | 1.11 (0.97-1.26) | | rs2167270 | G/A | 1630 | 478 | 0.227 | 1599 | 535 | 0.251 | 0.071 | 0.079 | 1.14 (0.99-1.31) | 1.14 (0.99-1.31) | LEPR | rs12405556 | T/G | 1775 | 333 | 0.158 | 1802 | 332 | 0.156 | 0.833 | 0.850 | 0.98 (0.83-1.16) | 0.98 (0.83-1.16) | JAK1 | rs17127107 | C/G | 1454 | 654 | 0.310 | 1451 | 683 | 0.320 | 0.491 | 0.610 | 1.05 (0.92-1.20) | 1.04 (0.91-1.18) | | rs10889502 | C/G | 1400 | 708 | 0.336 | 1385 | 749 | 0.351 | 0.310 | 0.292 | 1.07 (0.94-1.22) | 1.07 (0.94-1.22) | JAK2 | rs7849191 | C/T | 1330 | 778 | 0.369 | 1349 | 785 | 0.368 | 0.932 | 0.963 | 0.99 (0.88-1.13) | 1.00 (0.88-1.13) | STAT3 | rs9891119 | A/C | 1170 | 938 | 0.445 | 1159 | 975 | 0.457 | 0.431 | 0.451 | 1.05 (0.93-1.18) | 1.05 (0.93-1.19) | SHP-2 | rs4767860 | A/G | 1401 | 705 | 0.335 | 1390 | 742 | 0.348 | 0.360 | 0.334 | 1.06 (0.93-1.21) | 1.07 (0.94-1.22) | PPARGC1A | rs2970847 | C/T | 1604 | 504 | 0.239 | 1623 | 511 | 0.239 | 0.982 | 0.872 | 1.00 (0.87-1.15) | 1.01 (0.88-1.16) | | rs6821591 | T/C | 1419 | 689 | 0.327 | 1442 | 692 | 0.324 | 0.863 | 0.782 | 0.99 (0.87-1.12) | 0.98 (0.86-1.12) | PRKAA1 | rs249429 | T/C | 1654 | 454 | 0.215 | 1652 | 482 | 0.226 | 0.411 | 0.543 | 1.06 (0.92-1.23) | 1.05 (0.90-1.21) | | rs3805486 | A/G | 1608 | 500 | 0.237 | 1642 | 492 | 0.231 | 0.614 | 0.961 | 0.96 (0.84-1.11) | 1.00 (0.86-1.15) | PRKAA2 | rs1342382 | T/A | 1567 | 541 | 0.257 | 1598 | 536 | 0.251 | 0.680 | 0.721 | 0.97 (0.84-1.12) | 0.97 (0.85-1.12) | | rs6588640 | G/A | 1567 | 541 | 0.257 | 1611 | 523 | 0.245 | 0.392 | 0.373 | 0.94 (0.82-1.08) | 0.94 (0.81-1.08) | PRKAB2 | rs6937 | C/T | 1167 | 941 | 0.446 | 1131 | 1002 | 0.470 | 0.123 | 0.272 | 1.10 (0.97-1.25) | 1.07 (0.95-1.22) | | rs3766522 | A/T | 1875 | 233 | 0.111 | 1864 | 270 | 0.127 | 0.112 | 0.241 | 1.17 (0.97-1.41) | 1.12 (0.93-1.36) | | rs10783299 | T/C | 1114 | 994 | 0.472 | 1152 | 980 | 0.460 | 0.451 | 0.531 | 0.95 (0.85-1.08) | 0.96 (0.85-1.09) | PRKAG2 | rs5017427 | G/A | 1475 | 633 | 0.300 | 1541 | 593 | 0.278 | 0.112 | 0.130 | 0.90 (0.79-1.02) | 0.90 (0.79-1.03) | | rs9648724 | G/A | 1605 | 503 | 0.239 | 1621 | 511 | 0.240 | 0.933 | 0.990 | 1.01 (0.87-1.16) | 1.00 (0.86-1.16) | PRKAG3 | rs645163 | C/T | 1211 | 897 | 0.426 | 1205 | 929 | 0.435 | 0.521 | 0.654 | 1.04 (0.92-1.17) | 1.03 (0.91-1.16) | | rs6436094 | G/A | 1175 | 933 | 0.443 | 1196 | 938 | 0.440 | 0.840 | 0.992 | 0.99 (0.88-1.11) | 1.00 (0.88-1.13) | Alpha-MSH | rs6713532 | C/T | 1241 | 867 | 0.411 | 1257 | 877 | 0.411 | 0.982 | 0.922 | 1.00 (0.88-1.13) | 1.01 (0.89-1.14) | NPY | rs16147 | C/T | 1343 | 765 | 0.363 | 1382 | 748 | 0.351 | 0.432 | 0.331 | 0.95 (0.84-1.08) | 0.94 (0.83-1.07) |
|
|